Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
What To Include In A Retirement Portfolio At 30
Knowing what to include in your retirement portfolio at 30 can set you up for success. Learn about essential assets and strategies.
20,742 articles
KeyBanc Flags AeroVironment as Iran Conflict Winner (AVAV)
KeyBanc maintains an overweight stance on AeroVironment after Q3 results, signaling the stock could benefit from esca...
Three Best Dividend ETFs Every Market Dip Watch Today
Markets pull back in early 2026 amid geopolitical tensions. This article highlights three dividend-focused ETFs that ...
Return “Easy” Real Estate: Could 2026 Get Better for Buyers
The idea of easier real estate deals may be returning. This guide lays out what to watch for in 2026 and practical st...
Assertio (ASRT) 2025 Earnings: What Investors Watch
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
4,300%, Biggest Reason Carvana Investors Missed
Carvana’s stock run looked extraordinary, up 4,300% in three years. But the strongest buy signal wasn’t the hype—it w...
What Netflix Becomes Next: Path to a Trillion-Dollar Stock
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
3 Latin American Fintechs That Are Growing Faster Than You Think
Across Latin America, a new wave of fintechs is defying expectations. This article dives into three standout players,...
Shares Goodyear Popped Higher: What It Means for Investors
Goodyear’s stock surged intraday as oil prices pulled back and demand expectations shifted. Learn what drove the move...
Wall Street Wrong About Coinbase and Circle Stock Today
Investors often react to headlines about Coinbase and Circle with a knee-jerk fear or optimism. This piece explains w...
Applovin Stock Falling Hard: What Investors Need Today
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...
Crinetics Director Sells 5,000 Shares: Key Takeaways
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status